Prospective study regarding the improving effect of Go-sha-jinki-gan on frailty(Single-group, open-label study)

Hagihara Keisuke0 个研究点目标入组 20 人开始时间: 2019年11月7日最近更新: 2024年4月1日

适应症

试验速览

暂无简介。

•1) Patients who meet a criterion for frailty or pre-frailty by J-CHS.
•2) Patients with low muscle strength(hand grip strength: less than 26 kg for men and 18 kg for women) or low physical performance (below normal gait speed 1m/s)
•3) Patients who are 65 years old or older at the time of informed consent and do not received certification of needed support or needed long-term care.
•4) Patients who can go to hospital for outpatient.
•5) Patients who can take Kampo medicine preparations orally.
•6) Patients who obtained written consent for this study.

•1)Patients who took Kampo medicine preparation within 4 weeks from the start of treatment.
•2)Patients who have allergic episode with Kampo medicine preparations in the past.
•3)Patients with obvious joint deformities due to rheumatoid arthritis etc.
•4)Patients who has serious complicated disease (disease such as liver, kidney, heart, lung, blood, metabolic, or malignant tumor).
•5)Patients who have embedded medical devices such as cardiac pacemakers.
•6)Patients suspected of having dementia (MMSE score 23 or below).
•7)Patients who are participating in or are planning to participate in clinical trials or other clinical studies.
•8)Patients who are considered ineligible to participate by principal investigator or sub-investigator.

发起方

Hagihara Keisuke